A New Era: Animal Production Without Animals?
Recent years of intensive stem cell research have led to many advances in understanding cellular processes. Consequently, many more physiological processes can be replicated in vitro, that means outside the body using solely cells. The basis for industrial use of these findings is the mass proliferation of cells.
Products Based on Cells from Different Organisms
CellTec Systems holds an internationally patented and proven procedure for this challenging task, which can be universally used for most cell types. Additional patents from CellTec Systems cover various technologies for handling cell cultures.
Bio-Pioneers for Scalable Cell Production
Global challenges such as climate warming, feeding a growing global population while simultaneously facing resource and water scarcity, decreasing agricultural land, and many more, necessitate the development of sustainable solutions to preserve the living standards for future generations.
Industrial cell technology can make a significant contribution here. The result is a significantly improved conversion efficiency of raw materials into food, pet food, and many other animal-based products, as well as fewer greenhouse gas emissions, improved animal welfare, and reduced land use.
Value Chain of the Proven CellTec Systems Platform
As a system provider, CellTec Systems offers a broad technology platform developed to address these challenges. This ranges from gentle biopsy through the processing and preservation of cells to production in a modern bioreactor using various internationally patented processes. From a single cell, many tons of high-quality cell mass can be obtained resource-efficiently and cost-effectively. The process has already been successfully demonstrated at the laboratory scale.
Diverse Usage Scenarios
As a system provider, CellTec Systems covers the entire value chain of industrial cell proliferation and processing. There is currently a very high need for solutions in all relevant industries in this area. In addition to realizing its own reactor as a closed cell production system, the company offers a comprehensive service portfolio in all associated areas, namely bioengineering, knowledge transfer, and prototype production of industrial cell quantities.
Therefore, in the near future, the following sectors are particularly relevant as users:
Food and Feed (systems for efficient and environmentally friendly production of cruelty-free and high-quality cell quantities)
Chemistry and Cosmetics (proliferation of specific cells that enable the production of certain chemical substances as a culture, e.g., collagens from various animal species or cellular messengers)
Pharma (production of specific cell quantities, e.g., for antibody testing systems)
Why Now?
By 2035, a global market volume in the alternative protein sector of about $290 billion is expected (source BCG). Industrial cell culture will take a significant share in this area. Additionally, a considerable reduction in the environmental impact of our globally increasing meat production needs to be achieved. This is not possible by traditional means. Despite all existing risks, now it is the optimal time to engage with this topic.
Therefore, some companies are currently striving to participate in these opportunities. However, the industrial scaling problem can often only be solved through genetic modification of the cells.
The CellTec Systems team is at the forefront with innovative research and development for alternative solutions that can do without genetically modified cells!